NCT07224958

Brief Summary

The aim of this study is to conduct a comparative evaluation of the ROAM OA Single Upright Brace and the Ossur Unloader One Knee Brace in subjects with medial compartment osteoarthritis. The focus is on comparing the immediate and short-term biomechanical effects of these braces on knee adduction moments and spatiotemporal gait parameters, as well as assessing the long-term efficacy of the ROAM OA brace in improving pain and functional outcomes for individuals with osteoarthritis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
10mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Apr 2026Apr 2027

First Submitted

Initial submission to the registry

October 28, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 5, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

April 27, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

May 12, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

October 28, 2025

Last Update Submit

May 10, 2026

Conditions

Keywords

knee bracegait analysis

Outcome Measures

Primary Outcomes (2)

  • Change in knee adduction moment during gait

    Change in peak knee adduction moment measured during gait analysis using instrumented motion capture and force platforms. Comparisons are made between baseline, 4 weeks, and 8 weeks.

    Baseline, 4 weeks, and 8 weeks

  • Change in Visual Analog Scale (VAS) walking pain

    Change in walking pain measured by the Visual Analog Scale (VAS), in which participants rate their pain during walking along a 10-centimeter line ranging from 0 = no pain to 10 = worst imaginable pain. Lower scores indicate less pain and therefore a better outcome. Comparisons will be made between baseline, 4 weeks, and 8 weeks.

    Baseline, 4 weeks, and 8 weeks

Secondary Outcomes (2)

  • Change in KOOS (Knee injury and Osteoarthritis Outcome Score) subscale scores

    Baseline, 4 weeks, and 8 weeks

  • Change in knee range of motion (ROM)

    Baseline, 4 weeks, and 8 weeks

Study Arms (2)

ROAM OA brace

EXPERIMENTAL

Participants receive the ROAM OA Single Upright Knee Brace (Enovis) to wear daily for the study duration. The brace is designed to offload the medial compartment of the knee and improve pain and function.

Device: ROAM OA Single Upright Knee Brace

Active Comparator: Unloader brace or standard of care

ACTIVE COMPARATOR

Participants receive the Ossur Unloader One knee brace or no brace (standard of care) and will follow standard pain management and physical therapy guidelines. This group serves as an active comparator to the ROAM OA brace.

Device: Ossur Unloader One Knee Brace or Standard of Care

Interventions

A commercially available single-upright knee brace designed to offload the medial compartment of the knee in patients with unicompartmental osteoarthritis; manufactured by Enovis. Participants will wear the brace daily for the duration of the study.

ROAM OA brace

Participants will receive the Ossur Unloader One knee brace or no brace (standard of care) and will follow standard management and physical therapy guidelines. This group serves as the active comparator to the ROAM OA brace.

Active Comparator: Unloader brace or standard of care

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 40-85 years.
  • BMI ≤ 35.
  • Physician-diagnosed medial compartment knee osteoarthritis.
  • Visual Analog Scale (VAS) walking pain ≥ 4.
  • Willing to wear assigned brace ≥ 4 hours/day.
  • Able to walk independently for 20 minutes unaided.
  • Stable pain medication regimen ≥ 4 weeks.
  • ≥3 months since last hyaluronic acid (HA), platelet-rich plasma (PRP), or steroid injection.

You may not qualify if:

  • Lateral or patellofemoral osteoarthritis.
  • Prior knee replacement.
  • Significant ligament injury or acute lower limb injury.
  • Neurological condition affecting gait.
  • Severe psychiatric or neurological disorder affecting pain perception.
  • Skin condition or allergy preventing brace use.
  • Current use of another brace or assistive device.
  • Recent opioid or corticosteroid use (\<4 weeks).
  • Pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

RECRUITING

Related Publications (2)

  • Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74. doi: 10.1002/acr.21596.

    PMID: 22563589BACKGROUND
  • Chang J, Yuan Y, Fu M, Wang D. Health-related quality of life among patients with knee osteoarthritis in Guangzhou, China: a multicenter cross-sectional study. Health Qual Life Outcomes. 2023 May 27;21(1):50. doi: 10.1186/s12955-023-02133-x.

    PMID: 37244981BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Central Study Contacts

Markus Wimmer, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No blinding; all participants and study team are aware of the assigned brace.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized crossover assignment followed by a parallel continuation period. Participants will cross over between the ROAM OA brace and the comparator, then continue in a chosen brace for the remainder of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Grainger Director of the RUSH Arthritis and Orthopedics Institute

Study Record Dates

First Submitted

October 28, 2025

First Posted

November 5, 2025

Study Start

April 27, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

May 12, 2026

Record last verified: 2026-04

Locations